These boards are cropping up around the US as neurologists acclimate to a new class of drugs, but not everyone agrees such ...

Eli Lilly and Company (NYSE:LLY), a leading pharmaceutical giant with a market capitalization of $724 billion, has been ...

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span ...

First Solar will report financial results for the fourth quarter and full year ended Dec. 31, 2024, after the closing bell on ...

Effective February 10, 2025, Mamilli will assume global responsibility for the Informatics function for the Roche Group.

Plus: How AI propelled Nvidia up the list and other insights from this year's survey of corporate reputations.

President Donald Trump’s Medicare agency is seeking to bring more transparency to the US government’s drug price negotiation ...

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

A new study suggests clinical utility of the first FDA-approved genetic test to help gauge an individual’s risk for opioid ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the ...

The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.